Company
United StatesPublic company, NASDAQ: ANIPANI Pharmaceuticals, Inc. (NASDAQ: ANIP), Baudette, MN – FDA Inspections
Inspection records and compliance data for ANI Pharmaceuticals, Inc. in Baudette, Minnesota. 11 FDA inspections on record, 1 Form 483, last inspected December 06, 2024. Publicly traded as NASDAQ: ANIP.
Company Profile
This profile covers ANI Pharmaceuticals, Inc. based in Baudette, Minnesota, United States.
FDA Inspection History
- FDA inspections
- 11
- OAI
- 0
- VAI
- 6
- NAI
- 3
- Unclassified
- 2
- Form 483s
- 1
- Warning letters
- 0
First inspected January 28, 2010. Last inspected December 6, 2024.
Most cited issue areas
- Scientifically sound laboratory controls1 inspection
FDA inspections (11)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 6, 2024 | Not classified | Human Drugs | 1250465 |
| November 18, 2022 | VAI | Human Drugs · Drug Quality Assurance | 1191619 |
| April 12, 2019 | NAI | Human Drugs · Bioresearch Monitoring | 1089435 |
| May 18, 2017 | Not classified | Human Drugs | 1016454 |
| July 28, 2016 | VAI | Human Drugs · Bioresearch Monitoring | 983493 |
| September 27, 2013 | VAI | Human Drugs · Bioresearch Monitoring | 852937 |
| January 6, 2012 | VAI | Human Drugs · Unapproved and Misbranded Drugs | 762035 |
| September 16, 2011 | VAI | Human Drugs · Unapproved and Misbranded Drugs | 745033 |
| September 15, 2011 | NAI | Human Drugs · Drug Quality Assurance | 745327 |
| January 29, 2010 | VAI | Human Drugs · Drug Quality Assurance | 643297 |
| January 28, 2010 | NAI | Human Drugs · Drug Quality Assurance | 643298 |
FDA documents
People (6)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
ANI Pharmaceuticals, Inc.
Stock ticker
ANIP
Exchange
NASDAQ
Share price
$71.06
Market cap
$1.6B
Price as of
November 13, 2026
FEI Number
2111358
Address
210 W Main St, Baudette, Minnesota 56623, United States
Country
United States
ID: 8ba70b88-4d7d-4766-8dda-f4b44b5c35e3